NCT04446962
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT04446962
Title LOC-R01 Study of Lenalidomide and Ibrutinib in Association With Rituximab-Methotrexate Procarbazine Vincristin (R-MPV) (LOC-R01)
Acronym LOC-R01
Recruitment Active, not recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Institut Curie
Indications
Therapies
Age Groups: adult | senior
Covered Countries FRA

Facility Status City State Zip Country Details
CHU Amiens Amiens France Details
CHU Angers Angers France Details
CH côte Basque Bayonne 64100 France Details
CHU Besançon Besançon France Details
Institut Bergonié Bordeaux France Details
CHU Caen Caen France Details
CHU Clermont-Ferrand Clermont-Ferrand France Details
CH Colmar Colmar France Details
CHU Créteil Créteil France Details
CHU Dijon Dijon France Details
CHU Grenoble Grenoble France Details
CHRU Lille Lille 69000 France Details
CHU Limoges Limoges France Details
CHU Lyon Lyon France Details
CHU La Timone Marseille Marseille France Details
CHU Nancy Nancy France Details
CHU Nantes Nantes France Details
Centre Lacassagne Nice France Details
CHU Nîmes - Carémeau Nîmes 30029 France Details
Institut Curie Paris 75005 France Details
Hôpital Cochin Paris 75006 France Details
CHU Pitié-Salpêtrière Paris 75013 France Details
CHU Poitiers Poitiers France Details
CHU Rennes Rennes 35000 France Details
Centre Henri Becquerel Rouen 76000 France Details
CHU Strasbourg-Hôpital Hautepierre Strasbourg 67098 France Details
IUCT -Oncopole Toulouse France Details
CHU Tours Tours France Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field